Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175

[1]  Christopher Wilhelm,et al.  Targeting mitochondrial dysfunction can restore antiviral activity of NK cells in HIV/HCV coinfection , 2019, 35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber.

[2]  B. Puschner,et al.  Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy , 2018, Journal of veterinary internal medicine.

[3]  J. Li,et al.  A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[4]  A. Rezayan,et al.  Enhanced Entrapment and Improved in Vitro Controlled Release of N‐Acetyl Cysteine in Hybrid PLGA/Lecithin Nanoparticles Prepared Using a Nanoprecipitation/Self‐Assembly Method , 2017, Journal of cellular biochemistry.

[5]  P. Calder.  Omega-3 fatty acids and inflammatory processes: from molecules to man. , 2017, Biochemical Society transactions.

[6]  M. Sankian,et al.  Mycobacterium tuberculosis HspX/EsxS Fusion Protein: Gene Cloning, Protein Expression, and Purification in Escherichia coli. , 2017, Reports of biochemistry & molecular biology.

[7]  R. Fontana,et al.  Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor. , 2017, Journal of hepatology.

[8]  Y. Panahi,et al.  Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial , 2017, Drug Research.

[9]  A. Mosavat,et al.  CFP10: mFcγ2 as a novel tuberculosis vaccine candidate increases immune response in mouse , 2017, Iranian journal of basic medical sciences.

[10]  R. Sadeghi,et al.  Middle East Mycobacterium tuberculosis Antibiotic Resistance: A Systematic Review and Meta-Analysis , 2017 .

[11]  Lei Dong,et al.  Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress. , 2016, Clinical nutrition.

[12]  Ruchi Bansal,et al.  Clinical Advancements in the Targeted Therapies against Liver Fibrosis , 2016, Mediators of inflammation.

[13]  R. Sadeghi,et al.  The role of Toll-like receptor gene polymorphisms in tuberculosis susceptibility: a systematic review and meta- analysis , 2016 .

[14]  Xianjun Meng,et al.  Lonicera caerulea berry extract suppresses lipopolysaccharide-induced inflammation via Toll-like receptor and oxidative stress-associated mitogen-activated protein kinase signaling. , 2016, Food & function.

[15]  M. Sankian,et al.  Chitosan (CHT) and trimethylchitosan (TMC) nanoparticles as adjuvant/delivery system for parenteral and nasal immunization against Mycobacterium tuberculosis (MTb) ESAT-6 antigen , 2016 .

[16]  M. Pagliassotti,et al.  Endoplasmic reticulum stress in obesity and obesity-related disorders: An expanded view. , 2016, Metabolism: clinical and experimental.

[17]  S. Asgary,et al.  Treatment of Non‐alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo‐controlled Trial , 2016, Phytotherapy research : PTR.

[18]  Yan-Yan Zhang,et al.  (-)-Epigallocatechin-3-gallate (EGCG) attenuates arsenic-induced cardiotoxicity in rats. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  M. Santoro,et al.  ROS homeostasis and metabolism: a dangerous liason in cancer cells , 2016, Cell Death and Disease.

[20]  A. Mosavat,et al.  Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis , 2016, Molecular Biology Reports.

[21]  S. Cai,et al.  Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation. , 2016, Antioxidants & redox signaling.

[22]  D. Rockey,et al.  The mitochondria-targeted antioxidant MitoQ attenuates liver fibrosis in mice. , 2016, International journal of physiology, pathophysiology and pharmacology.

[23]  S. J. Sucheck,et al.  Recent Advances in Subunit Vaccine Carriers , 2016, Vaccines.

[24]  B. Jha,et al.  Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma. , 2016, Cancer research.

[25]  A. Mosavat,et al.  Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[26]  M. El-Awady,et al.  Pomegranate protects liver against cecal ligation and puncture-induced oxidative stress and inflammation in rats through TLR4/NF-κB pathway inhibition. , 2016, Environmental toxicology and pharmacology.

[27]  Hyung-Ryong Kim,et al.  Endoplasmic Reticulum Stress and Associated ROS , 2016, International journal of molecular sciences.

[28]  Z. Beck,et al.  Liposomal adjuvants for human vaccines , 2016, Expert opinion on drug delivery.

[29]  Q. Wang,et al.  A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis , 2016, Human vaccines & immunotherapeutics.

[30]  D. Brenner,et al.  The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts , 2016, Front. Physiol..

[31]  H. Forman,et al.  Redox homeostasis: The Golden Mean of healthy living , 2016, Redox biology.

[32]  C. Aiken,et al.  Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth1 , 2015, The American journal of clinical nutrition.

[33]  Youming Li,et al.  Association of homocysteine level with biopsy-proven non-alcoholic fatty liver disease: a meta-analysis , 2015, Journal of clinical biochemistry and nutrition.

[34]  J. Chen,et al.  NIM811 downregulates transforming growth factor‑β signal transduction in vivo and in vitro. , 2016, Molecular medicine reports.

[35]  J. Demarquoy,et al.  Crosstalk between mitochondria and peroxisomes. , 2015, World journal of biological chemistry.

[36]  Tilman Grune,et al.  Clinical Relevance of Biomarkers of Oxidative Stress , 2015, Antioxidants & redox signaling.

[37]  A. Mosavat,et al.  APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice , 2015, Applied Microbiology and Biotechnology.

[38]  Kamil Kuča,et al.  Redox- and non-redox-metal-induced formation of free radicals and their role in human disease , 2015, Archives of Toxicology.

[39]  Zhang-Chun Li,et al.  Quercetin protects mouse liver against CCl₄-induced inflammation by the TLR2/4 and MAPK/NF-κB pathway. , 2015, International immunopharmacology.

[40]  D. Jump,et al.  Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr−/− mice , 2015, Proceedings of the Nutrition Society.

[41]  D. Brenner,et al.  Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation , 2015, PloS one.

[42]  Shuijun Zhang,et al.  Protective Effects of Salubrinal on Liver Injury in Rat Models of Brain Death , 2015, Chinese medical journal.

[43]  R. Brosch,et al.  Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. , 2015, Vaccine.

[44]  C. Trautwein,et al.  Hepatic fibrosis: Concept to treatment. , 2015, Journal of hepatology.

[45]  Abolghasem Jouyban,et al.  Reliability of malondialdehyde as a biomarker of oxidative stress in psychological disorders , 2015, BioImpacts : BI.

[46]  F. Gonzalez,et al.  Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy , 2015, BBA clinical.

[47]  Fang Yuan,et al.  Minocycline protects against hepatic ischemia/reperfusion injury in a rat model. , 2015, Biomedical reports.

[48]  S. Batra,et al.  NADPH oxidases: an overview from structure to innate immunity-associated pathologies , 2014, Cellular and Molecular Immunology.

[49]  R. Sarhan,et al.  Biochemical assessment of oxidative status versus liver enzymes in patients with chronic fascioliasis , 2015, Journal of Parasitic Diseases.

[50]  Mona F. Mahmoud,et al.  Limonin attenuates hepatocellular injury following liver ischemia and reperfusion in rats via toll-like receptor dependent pathway. , 2014, European journal of pharmacology.

[51]  Joo Yeon Park,et al.  Nanotechnology and vaccine development , 2014 .

[52]  P. Calder,et al.  Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study , 2014, Hepatology.

[53]  M. Farhangi,et al.  Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. , 2014, Archives of medical research.

[54]  D. O'hagan,et al.  Designing and building the next generation of improved vaccine adjuvants. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[55]  M. Ehrich,et al.  In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters , 2014, Nanoscale Research Letters.

[56]  D. H. Kim,et al.  Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro. , 2014, Life sciences.

[57]  R. Schwendener,et al.  Liposomes as vaccine delivery systems: a review of the recent advances , 2014, Therapeutic advances in vaccines.

[58]  H. Cichoż-Lach,et al.  Oxidative stress as a crucial factor in liver diseases. , 2014, World journal of gastroenterology.

[59]  S. Kaufmann,et al.  Novel vaccination strategies against tuberculosis. , 2014, Cold Spring Harbor perspectives in medicine.

[60]  G. Zhai,et al.  Recent advances in active hepatic targeting drug delivery system. , 2014, Current drug targets.

[61]  Jamey D. Young,et al.  ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload , 2014, Molecular metabolism.

[62]  N. Chandel,et al.  ROS Function in Redox Signaling and Oxidative Stress , 2014, Current Biology.

[63]  F. Nassir,et al.  Role of Mitochondria in Nonalcoholic Fatty Liver Disease , 2014, International journal of molecular sciences.

[64]  Yujun Jiang,et al.  Protective Effects of Lactobacillus plantarum NDC 75017 Against Lipopolysaccharide-Induced Liver Injury in Mice , 2014, Inflammation.

[65]  H. Qian,et al.  Aloin protects against chronic alcoholic liver injury via attenuating lipid accumulation, oxidative stress and inflammation in mice , 2014, Archives of Pharmacal Research.

[66]  F. Nassir,et al.  Role of mitochondria in alcoholic liver disease. , 2014, World journal of gastroenterology.

[67]  S. Xiong,et al.  A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection , 2014, Human vaccines & immunotherapeutics.

[68]  E. Niki.  Biomarkers of lipid peroxidation in clinical material. , 2014, Biochimica et biophysica acta.

[69]  Y. Perrie,et al.  Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl‐sn‐glycero‐3‐phosphocholine content in liposomal adjuvants , 2013, The Journal of pharmacy and pharmacology.

[70]  D. Vecchio,et al.  Signaling pathways involved in isoprostane-mediated fibrogenic effects in rat hepatic stellate cells. , 2013, Free radical biology & medicine.

[71]  L. Wojtczak,et al.  Interaction of the antibiotic minocycline with liver mitochondria – role of membrane permeabilization in the impairment of respiration , 2013, The FEBS journal.

[72]  L. Zhuo,et al.  Asiatic acid from Potentilla chinensis attenuate ethanol-induced hepatic injury via suppression of oxidative stress and Kupffer cell activation. , 2013, Biological & pharmaceutical bulletin.

[73]  P. Fischer,et al.  Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice , 2013, Science Translational Medicine.

[74]  S. Geary,et al.  Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses , 2013, Human vaccines & immunotherapeutics.

[75]  Hongjuan Yu,et al.  Subunit Vaccine Consisting of Multi-Stage Antigens Has High Protective Efficacy against Mycobacterium tuberculosis Infection in Mice , 2013, PloS one.

[76]  H. McShane,et al.  Vaccination against tuberculosis: how can we better BCG? , 2013, Microbial pathogenesis.

[77]  B. Zhu,et al.  Systems approach to tuberculosis vaccine development , 2013, Respirology.

[78]  S. Kaufmann.  Tuberculosis vaccines: time to think about the next generation. , 2013, Seminars in immunology.

[79]  Laura J. Dixon,et al.  Kupffer cells in the liver. , 2013, Comprehensive Physiology.

[80]  Kenneth A. Philbrick,et al.  Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. , 2013, The Journal of nutrition.

[81]  B. Bartosch,et al.  Hepatitis C Virus-Induced Mitochondrial Dysfunctions , 2013, Viruses.

[82]  A. Zorzano,et al.  Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. , 2013, International review of cell and molecular biology.

[83]  Jian-Gao Fan,et al.  Randomized, Vitamin E-Controlled Trial of Bicyclol Plus Metformin in Non-Alcoholic Fatty Liver Disease Patients with Impaired Fasting Glucose , 2013, Clinical Drug Investigation.

[84]  A. Khamesipour,et al.  The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen. , 2012, Experimental parasitology.

[85]  N. Chavez-Tapia,et al.  Role of oxidative stress and molecular changes in liver fibrosis: a review. , 2012, Current medicinal chemistry.

[86]  C. Hoppel,et al.  Oxidation of Fatty Acids Is the Source of Increased Mitochondrial Reactive Oxygen Species Production in Kidney Cortical Tubules in Early Diabetes , 2012, Diabetes.

[87]  M. H. Santana,et al.  Effectiveness, against tuberculosis, of pseudo-ternary complexes: peptide-DNA-cationic liposome. , 2012, Journal of colloid and interface science.

[88]  S. Kaufmann,et al.  Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go? , 2012, PLoS pathogens.

[89]  J. Kong,et al.  Oxidative stress in neurodegenerative diseases , 2012, Neural regeneration research.

[90]  Hongjuan Yu,et al.  Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX. , 2011, Vaccine.

[91]  H. McShane,et al.  Tuberculosis vaccines: progress and challenges. , 2011, Trends in pharmacological sciences.

[92]  O. Firuzi,et al.  Antioxidant therapy: current status and future prospects. , 2011, Current medicinal chemistry.

[93]  S. Malik,et al.  HEPATOPROTECTIVE EFFECTS OF BERBERIS LYCIUM, GALIUM APARINE AND PISTACIA INTEGERRIMA IN CARBON TETRACHLORIDE (CCL4)-TREATED RATS , 2011 .

[94]  Amal A. Baalash,et al.  Biochemical Study of Oxidative Stress Markers in the Liver, Kidney and Heart of High Fat Diet Induced Obesity in Rats , 2011, Diabetology & metabolic syndrome.

[95]  K. Tsai,et al.  Salubrinal, an eIF2α dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model. , 2011, Free radical biology & medicine.

[96]  Y. Zhang,et al.  Immunogenicity and Protective Efficacy of a Fusion Protein Vaccine Consisting of Antigen Ag85B and HspX against Mycobacterium tuberculosis Infection in Mice , 2011, Scandinavian journal of immunology.

[97]  P. Portincasa,et al.  Mitochondria in chronic liver disease. , 2011, Current drug targets.

[98]  Y. Perrie,et al.  Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system. , 2011, Journal of pharmaceutical sciences.

[99]  N. Garçon,et al.  Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems , 2011, Expert review of vaccines.

[100]  Sang-Nae Cho,et al.  The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis. , 2011, Microbes and infection.

[101]  N. Gu,et al.  Cationic liposomes as gene delivery system: transfection efficiency and new application. , 2011, Die Pharmazie.

[102]  J. Praestgaard,et al.  Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy. , 2011, Antiviral research.

[103]  Hasibur Rehman,et al.  NIM811 Prevents Mitochondrial Dysfunction, Attenuates Liver Injury, and Stimulates Liver Regeneration After Massive Hepatectomy , 2010, Transplantation.

[104]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[105]  M. Macías-Silva,et al.  Angiotensin II increases mRNA levels of all TGF‐β isoforms in quiescent and activated rat hepatic stellate cells , 2010, Cell biology international.

[106]  Robin A. J. Smith,et al.  The mitochondria‐targeted anti‐oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[107]  T. Billiar,et al.  Linking oxidative stress to inflammation: Toll-like receptors. , 2010, Free radical biology & medicine.

[108]  T. Waldmann,et al.  Highly Persistent and Effective Prime/Boost Regimens against Tuberculosis That Use a Multivalent Modified Vaccine Virus Ankara-Based Tuberculosis Vaccine with Interleukin-15 as a Molecular Adjuvant , 2010, Clinical and Vaccine Immunology.

[109]  L. Rajendran,et al.  Subcellular targeting strategies for drug design and delivery , 2010, Nature Reviews Drug Discovery.

[110]  Yuba Raj Pokharel,et al.  Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression. , 2009, Toxicology and applied pharmacology.

[111]  Hongjuan Yu,et al.  Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. , 2009, Vaccine.

[112]  D. Brenner,et al.  Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[113]  F. Gonzalez,et al.  Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress. , 2009, Journal of hepatology.

[114]  J. Christensen,et al.  CD4 and CD8 T Cell Responses to the M. tuberculosis Ag85B-TB10.4 Promoted by Adjuvanted Subunit, Adenovector or Heterologous Prime Boost Vaccination , 2009, PloS one.

[115]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[116]  C. Leclerc,et al.  Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. , 2009, Vaccine.

[117]  Yeong Shik Kim,et al.  Chlorogenic acid, a polyphenolic compound, treats mice with septic arthritis caused by Candida albicans. , 2008, International immunopharmacology.

[118]  P. Andersen,et al.  Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements , 2008, PloS one.

[119]  S. Ramos,et al.  Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes , 2008, BMC Immunology.

[120]  Jing Zhao,et al.  Protective effect of bicyclol on acute alcohol-induced liver injury in mice. , 2008, European journal of pharmacology.

[121]  C. Russell Middaugh,et al.  Nanotechnology in vaccine delivery☆ , 2008, Advanced Drug Delivery Reviews.

[122]  Y. Perrie,et al.  PLGA microspheres for the delivery of a novel subunit TB vaccine. , 2008, Journal of drug targeting.

[123]  M. Rosengart,et al.  HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling , 2007, The Journal of experimental medicine.

[124]  E. Agger,et al.  Cationic liposomes as vaccine adjuvants , 2007, Expert review of vaccines.

[125]  N. Kawada,et al.  Role of oxidative stress and Kupffer cells in hepatic fibrosis , 2007, Journal of gastroenterology and hepatology.

[126]  P. Andersen.  Vaccine strategies against latent tuberculosis infection. , 2007, Trends in microbiology.

[127]  J. Pincemail,et al.  [Oxidative stress]. , 2007, Revue medicale de Liege.

[128]  F. Szoka,et al.  Lipid-based Nanoparticles for Nucleic Acid Delivery , 2007, Pharmaceutical Research.

[129]  N. Nieto.  Oxidative‐stress and IL‐6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells , 2006, Hepatology.

[130]  Leaf Huang,et al.  Immunostimulation of dendritic cells by cationic liposomes , 2006, Molecular membrane biology.

[131]  M. Kieny,et al.  A review of vaccine research and development: tuberculosis. , 2005, Vaccine.

[132]  P. Andersen,et al.  Cationic Liposomes Containing Mycobacterial Lipids: a New Powerful Th1 Adjuvant System , 2005, Infection and Immunity.

[133]  G. Khuller,et al.  Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis. , 2005, Vaccine.

[134]  H. Cai,et al.  Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice. , 2005, Vaccine.

[135]  A. Thomas,et al.  Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. , 2005, Vaccine.

[136]  Min-Seon Kim,et al.  alpha-Lipoic acid prevents diabetes mellitus in diabetes-prone obese rats. , 2004, Biochemical and biophysical research communications.

[137]  Takahiro Suzuki,et al.  Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. , 2004, Gastroenterology.

[138]  Ann Williams,et al.  Protective Effect of a Tuberculosis Subunit Vaccine Based on a Fusion of Antigen 85B and ESAT-6 in the Aerosol Guinea Pig Model , 2004, Infection and Immunity.

[139]  H. Park,et al.  Cutting Edge: Direct Interaction of TLR4 with NAD(P)H Oxidase 4 Isozyme Is Essential for Lipopolysaccharide-Induced Production of Reactive Oxygen Species and Activation of NF-κB1 , 2004, The Journal of Immunology.

[140]  R. Glück,et al.  Influenza virosomes as an efficient system for adjuvanted vaccine delivery , 2004, Expert opinion on biological therapy.

[141]  P. Andersen,et al.  Combination of the Cationic Surfactant Dimethyl Dioctadecyl Ammonium Bromide and Synthetic Mycobacterial Cord Factor as an Efficient Adjuvant for Tuberculosis Subunit Vaccines , 2004, Infection and Immunity.

[142]  G. Gores,et al.  The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse , 2004, Journal of Pharmacology and Experimental Therapeutics.

[143]  L. Videla,et al.  Oxidative stress-mediated hepatotoxicity of iron and copper: Role of Kupffer cells , 2003, Biometals.

[144]  Norazmi Mohd Nor,et al.  Approaches towards the development of a vaccine against tuberculosis: recombinant BCG and DNA vaccine. , 2004, Tuberculosis.

[145]  M. Robin,et al.  Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress. , 2004, Diabetes.

[146]  A. Parrish,et al.  The role of hepatocellular oxidative stress in Kupffer cell activation during 1,2-dichlorobenzene-induced hepatotoxicity. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[147]  G. Kitas,et al.  Validation of a novel ELISA for measurement of MDA-LDL in human plasma. , 2003, Free radical biology & medicine.

[148]  I. Alexa,et al.  [Oxidative stress in atherosclerosis]. , 2003, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

[149]  Mitsuru Hashida,et al.  Factors affecting drug and gene delivery: effects of interaction with blood components. , 2002, Critical reviews in therapeutic drug carrier systems.

[150]  D. Johns,et al.  Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II. , 2002, American journal of physiology. Heart and circulatory physiology.

[151]  G. Robino,et al.  Oxidative stress-related molecules and liver fibrosis. , 2001, Journal of hepatology.

[152]  P. Andersen,et al.  Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6 , 2001, Infection and Immunity.

[153]  H. Zhu,et al.  Mitochondrial adaptations to obesity-related oxidant stress. , 2000, Archives of biochemistry and biophysics.

[154]  K. Hensley,et al.  Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. , 2000, Carcinogenesis.

[155]  David C. Jones,et al.  C ASE R EPORT: Oral antioxidant therapy for the treatment of primary biliary cirrhosis: A pilot study , 1999, Journal of gastroenterology and hepatology.

[156]  A. Boveris,et al.  Primary role of Kupffer cell–hepatocyte communication in the expression of oxidative stress in the post‐ischaemic liver , 1998, Cell biochemistry and function.

[157]  F. Ridolfi,et al.  Fibrogenic effect of oxidative stress on rat hepatic stellate cells , 1998, Hepatology.

[158]  S. Sherlock,et al.  Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trial. , 1980, Gut.